Effect of body weight on testosterone/estradiol ratio in oligozoospermic patients

Archives of Andrology

Volumn 52, Issue 2, 2006, Pages 97-102

  Fejes, I ^a   Koloszar S ^a   Zavaczki Z ^a   Daru, J ^a   Szollosi J ^a   Pal A ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Body mass index; Male fertility; Oligozoospermia; Testosterone estradiol ratio

Indexed keywords

ESTRADIOL; TESTOSTERONE;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; MALE; OBESITY; OLIGOSPERMIA; PRIORITY JOURNAL; SPERM; SPERMATOZOON DENSITY; STATISTICAL SIGNIFICANCE; TESTOSTERONE BLOOD LEVEL;

ADULT; BODY MASS INDEX; BODY WEIGHT; ESTRADIOL; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MALE; OBESITY; OLIGOSPERMIA; TESTOSTERONE;

EID: 79961134110     PISSN: 01485016     EISSN: 15210375     Source Type: Journal    
DOI: 10.1080/01485010500315479     Document Type: Article

References (18)

1. Bray GA (2002): The underlying basis for obesity: relationship to cancer. J Nutrition 132:3451S-3455S.
2. Camina JP, Lage M, et al. (2002): Evidence of free leptin in huan seminal plasma. Endocrine 17:169-174.
3. Carreau S, Genissel C, et al. (1999): Sources of oestrogen in the testis and reproductive tract of the male. Int J Androl 22:211-223.
4. Carreau S, Bourguiba S, et al. (2002): Reproductive system: aromatase and estrogens. Mol Cell Endocrinol 193:137-143.
5. Cohen PG (2001): Aromatase, adidosity, aging and disease. The hypogonadal metabolic-atherogenic-disease and aging connection. Meg Hypotheses 56:702-708.
6. Haidl G (2002): Management strategies for male factor infertility. Drugs 62:1741-1753.
7. Holbrook JM, Cohen PG (2003): Aromatase inhibition for the treatment of idiopathic hypogonadotropic hypogonadism in men with premature ejaculation. South Med J 96:544-547.
8. Jensen TK, Andersson A, et al. (2004): Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertil Steril 82:863-870.
9. Kamischke A, Behre HM, et al. (1998): Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial. Hum Reprod 13:596-603.
10. Kawakami E, Hirano T, et al. (2004): Improvement in spermatogenic function after subcutaneous implantation of a capsule containing an aromatase inhibitor in four oligozoospermic dogs and one azoospermic dog with high plasma estradiol-17beta concentrations. Theriogenology 62:165-178.
11. Koloszar S, Daru J, et al. (2002): Effect of female body weight on efficiency of donor AI. Arch of Androl 48:323-327.
12. Li X, Strauss L, et al. (2004): Multiple structural and functional abnormalities in the p450 aromatase expressing transgenic male mice are ameliorated by a p450 aromatase inhibitor. Am J Pathol 164:1039-1048.
13. Luboshitzky R, Kaplan-Zverling M, et al. (2002): Seminal plasma androgen/oestrogen balance in infertile men. Int J Androl 25:345-351.
14. Nieschlag E, Behre HM (2000): Andrology: male reproductive health and dysfunction. Berlin, Heidelberg, New York, Barcelona, Hong Kong, London, Milan, Paris, Singapore, Tokyo: Springer-Verlag, pp 40-41.
15. Raman JD, Schlegel PN (2002): Aromatase inhibitors for male infertility. J Urol 167:624-629.
16. Rami B, Schober E, et al. (2004): Prevalence of overweight and obesity in male adolescents in Austria between 1985 and 2000. A population based study. J Pediatr Endocrinol Metab 17:67-72.
17. Vermeulen A, Kaufman JM, et al. (2002): Estradiol in elderly men. Aging Male 5:98-102.
18. World Health Organization (1999): WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. Cambridge, UK Cambridge University Press, pp 4-22.